Letrozole (2.5mg) ""

Letrozole (2.5mg)
LETROZONE is a medication that belongs to a class of drugs known as aromatase inhibitors. LETROZONE is primarily used in the treatment of certain hormone receptor-positive breast cancers in postmenopausal women. LETROZONE works by inhibiting the enzyme aromatase, which is responsible for converting androgens (male hormones) into estrogens (female hormones) in the body. By blocking this conversion, LETROZONE reduces the levels of estrogen in the body, which can help slow down the growth of estrogen-sensitive breast cancers.
Breast cancer cells that are hormone receptor-positive rely on estrogen for their growth and proliferation. By lowering estrogen levels, LETROZONE helps to deprive these cancer cells of the hormone they need to grow, ultimately slowing down or halting the progression of the disease.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/letrozone-2-5-133664